The inhibition of glucose-6-phosphate dehydrogenase activity by dithranol (anthralin), zinc ions and/or salicylic acid.
D000873:Anthracenes / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D004338:Drug Combinations; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy / Q000201:enzymology; D012459:Salicylates / Q000627:therapeutic use; D012980:Sodium Salicylate; D015032:Zinc / Q000627:therapeutic use
D000873:Anthracenes; D004338:Drug Combinations; D012459:Salicylates; D005954:Glucosephosphate Dehydrogenase; D015032:Zinc; D012980:Sodium Salicylate